Imagion Biosystems Ltd., (ASX:IBX) an early cancer detection healthcare company based in Melbourne, Australia, announced it will be relocating to San Diego and expects to be fully operational in the second quarter of this year at its new home on Science Center Drive.

The move, according to a press release, comes as the company’s plans for the clinical testing of its MagSense cancer detection technology begins to solidify.

“Relocating to an active biotech community like San Diego will facilitate clinical development and open new opportunities for diagnostic and therapeutic collaborations,” Farideh Bischoff, the company’s vice president of clinical research, said in the new release.

Executive Chairman Bob Proulx said the medical need for earlier cancer detection is immediate. “As our MagSense™ technology progresses to first-in-human testing and towards commercialisation, it is important that we have ready access to the kind of skilled resources and supportive business environment that San Diego offers.”